Lp(a): a New Pathway to Target?

PURPOSE OF REVIEW: Over the past decades, genetic and observational evidence has positioned lipoprotein(a) as novel important and independent risk factor for cardiovascular disease (ASCVD) and aortic valve stenosis. RECENT FINDINGS: As Lp(a) levels are determined genetically, lifestyle interventions...

Descripción completa

Detalles Bibliográficos
Autores principales: Nurmohamed, Nick S., Kraaijenhof, Jordan M., Stroes, Erik S. G.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer US 2022
Materias:
Nonstatin Drugs (L. Tokgozoglu and A.L. Catapano, Section Editors)
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9534805/
https://www.ncbi.nlm.nih.gov/pubmed/36066785
http://dx.doi.org/10.1007/s11883-022-01060-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9534805/
https://www.ncbi.nlm.nih.gov/pubmed/36066785
http://dx.doi.org/10.1007/s11883-022-01060-4

Ejemplares similares